IATF approves COVID-19 clinical trials on pediatric age group

Clinical trials focused on fighting emerging variants of the COVID-19 virus might start soon, Malacañang announced on Saturday (Sept. 4).

The Inter-Agency Task Force (IATF), subject to the considerations of the Food and Drug Administration (FDA), approved the recommendation for sponsors or trialists.

The IATF plans to shift its focus towards people of different age groups and people with comorbidities, or the immunocompromised, to be more inclusive in addressing the COVID-19 pandemic, Presidential Spokesperson Harry Roque said in a statement.

The recommendation to prioritize Phase three clinical trials that will focus on the pediatric age group of six months to 12 years old was approved by the IATF last Sept.4.

The Phase three clinical trials will also include the elderly (more than 60 years old), pregnant mothers, patients with immunodeficiency, patients with autoimmune diseases, patients with renal diseases, and patients with chronic respiratory diseases. – PG – bny

Popular

Palace reacts to China’s ban on ex-Sen. Tolentino, former Pres. spox Roque statement; issues updates on probe of ‘missing sabungeros’

By Dean Aubrey Caratiquet At the Palace press briefing held this Wednesday, July 2, Presidential Communications Office (PCO) Undersecretary and Palace Press Officer Claire Castro...

Gov’t remains ‘relentless’ in supporting PH Air Force — PBBM

By Brian Campued President Ferdinand R. Marcos Jr. reaffirmed his administration’s continued support to the Filipino airmen and airwomen as the Philippine Air Force (PAF)...

PBBM ‘rings’ CMEPA into effectivity

By Dean Aubrey Caratiquet Investments serve as the lifeblood of a successful and progressive nation, paving the way for an economy that adopts to the...

‘Best is yet to come’: PBBM rallies Alex Eala after WTA finals debut

By Darryl John Esguerra | Philippine News Agency On Sunday, June 29, President Ferdinand R. Marcos Jr. offered words of encouragement to tennis sensation Alex...